We are live on ! Find out more
TECH icon

Bio-Techne

262 hedge funds and large institutions have $3.33B invested in Bio-Techne in 2014 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 82 increasing their positions, 87 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 27

6% more funds holding

Funds holding: 248262 (+14)

1% less capital invested

Capital invested by funds: $3.38B → $3.33B (-$48.9M)

6% less repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 87

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $231K

Holders
262
Holders Change
+14
Holders Change %
+5.65%
% of All Funds
6.99%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
45
Increased
82
Reduced
87
Closed
27
Calls
Puts
$231K
Net Calls
-$231K
Net Calls Change
-$44K
Name Holding Trade Value Shares
Change
Change in
Stake
Mackenzie Financial
26
Mackenzie Financial
Ontario, Canada
$42.5M -$604K -26,400 -1%
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$42.5M +$4.1M +179,360 +11%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$38.4M -$1.42M -62,068 -4%
Norges Bank
29
Norges Bank
Norway
$32.6M +$2.17M +94,724 +7%
WA
30
Wasatch Advisors
Utah
$31.5M -$111K -4,848 -0.4%
ACM
31
Atlanta Capital Management
Georgia
$31.3M +$4.53M +197,804 +17%
RFC
32
Russell Frank Company
Washington
$24.6M +$6.18M +269,912 +34%
Fidelity International
33
Fidelity International
Bermuda
$20.3M +$1.69M +73,912 +9%
Ameriprise
34
Ameriprise
Minnesota
$19.4M -$335K -14,632 -2%
Schroder Investment Management Group
35
Schroder Investment Management Group
United Kingdom
$18.9M -$815K -35,600 -4%
Janus Henderson Group
36
Janus Henderson Group
United Kingdom
$17.3M +$17.1M +746,912 New
Geode Capital Management
37
Geode Capital Management
Massachusetts
$17M +$548K +23,964 +3%
BTW
38
Boston Trust Walden
Massachusetts
$16.5M -$749K -32,740 -4%
Citadel Advisors
39
Citadel Advisors
Florida
$15.6M -$5.15M -224,924 -25%
CCA
40
Conestoga Capital Advisors
Pennsylvania
$15.4M -$544K -23,788 -3%
MAA
41
Managed Account Advisors
New Jersey
$13.6M -$635K -27,756 -5%
SIMG
42
Stephens Investment Management Group
Texas
$13.2M -$846K -36,960 -6%
TCIM
43
TIAA CREF Investment Management
New York
$12.9M +$1.41M +61,716 +12%
MSA
44
Mason Street Advisors
Wisconsin
$12.6M -$5.08M -221,980 -29%
EAM
45
Edge Asset Management
Washington
$10.8M +$2.39M +104,456 +29%
Dimensional Fund Advisors
46
Dimensional Fund Advisors
Texas
$10.1M +$2.89M +126,060 +41%
NFA
47
Nationwide Fund Advisors
Ohio
$9.94M -$649K -28,360 -6%
BIM
48
BlackRock Investment Management
Delaware
$9.52M -$73.8K -3,224 -0.8%
Principal Financial Group
49
Principal Financial Group
Iowa
$9.33M -$366K -16,012 -4%
SEI Investments
50
SEI Investments
Pennsylvania
$8.85M +$8.77M +383,276 New

TECH Hedge Fund Activity: Q4 2014 in Review

262 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q4 2014, worth a combined $3.33B — down 1.4% from $3.38B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new TECH positions and 27 closed out — a net gain of 18 holders — while 82 added to existing stakes and 87 trimmed.

The largest buyer was Mairs & Power Inc, adding an estimated $18.8M. The largest seller was Kayne Anderson Rudnick Investment Management, exiting entirely with an estimated $71M sold.

  • 262 institutional investors held Bio-Techne (TECH) as of Q4 2014, up from 248 in Q3 2014.
  • Funds reported $3.33B of Bio-Techne stock for Q4 2014, down 1.4% quarter-over-quarter.
  • 45 funds opened new Bio-Techne positions in Q4 2014 and 27 closed out, a net change of +18 holders.
  • The largest Bio-Techne buyer in Q4 2014 was Mairs & Power Inc, an estimated $18.8M added.
  • The largest Bio-Techne seller in Q4 2014 was Kayne Anderson Rudnick Investment Management, an estimated $71M sold.

Based on aggregated 13F filings for Q4 2014.